Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zenaida Fuentes
Institutions:
The University of Texas at San Antonio Health Science Center,
Vanderbilt University
Observed institutions:
The University of Texas at El Paso,
The University of Texas at San Antonio Health Science Center,
Vanderbilt University
ORCID:
0009-0009-7676-4449
Observed ORCID:
0009-0009-7676-4449
OpenAlex ID:
A5013939509
Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis
2025
·
Bianca Romo
, Zenaida Fuentes
, et al.
·
Cancers
·
2
Abstract LB015: CCR7-expressing T-cell acute lymphoblastic leukemia mouse model provides a platform for developing novel anti-CCR7 therapies to prevent CNS invasion
2022
·
Angel Torres
, Aaron Vazquez
, et al.
·
Cancer Research
·
2
Abstract 6030: Gli2 increases Osteopontin expression to alter cancer associated fibroblast behavior
2026
·
Zenaida Fuentes
, Rachel Mangano
, et al.
·
Cancer Research
Targeting LIPA with ERX-41 Induces ER Stress and Inhibits Tumor Progression in Inflammatory Breast Cancer
2026
·
Zenaida Fuentes
, Gaurav Sharma
, et al.
·
Biomolecules
Abstract 1630: Targeting the LIF/LIFR axis reduces the progression of inflammatory breast cancer by promoting ferroptosis
2025
·
Bianca A. Romo
, Zenaida Fuentes
, et al.
·
Cancer Research
Abstract 2100: Novel LIPA targeted therapy for treating inflammatory breast cancer
2024
·
Zenaida Fuentes
, Rahul Gopalam
, et al.
·
Cancer Research
Abstract 5986: Significance of LIF/LIFR axis in the progression of inflammatory breast cancer
2024
·
Bianca Romo
, Zenaida Fuentes
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
4
H-index:
2
I10-index:
Year
Topic
Type